Antero Midstream reported Q2 results on July 29, and the week's question has shifted from anticipation to verdict: did management's heavy spring selling look prescient or premature?
The backdrop heading into the print was already telling. Every insider trade recorded over the prior 90 days was a sale. CEO Michael Kennedy exited $2.2 million worth of shares in early May at $21.92. His March cluster added another $2.5 million. The CFO and Chief Compliance Officer piled in alongside, pushing aggregate net selling past $15 million. The stock closed the week at $21.75 — below those exit prices — which means the executives who sold in the $21.90–$23 range are currently sitting on gains relative to where the stock ended up. The week's 3.4% decline and a 6.2% one-month slide now put the share price beneath most of those transaction levels, handing the sellers at least a short-term vindication.
The positioning picture shifted noticeably around the earnings date. Short interest jumped 13.6% in a single session on July 28, pushing the estimated figure to 2.34% of the free float — up roughly 14% on the week. That remains a low absolute level, and the borrow market tells a less stressed story: availability, while dramatically tighter than last week's reading near 7,000%, is still extremely loose at around 1,830%. Cost to borrow ticked up 29% on the week to 0.46%, but that remains well inside "easy borrow" territory. The one-day SI spike looks more like a tactical hedge into the number than a conviction short. Options positioning held steady, with the put/call ratio at 0.23 — only marginally above its 20-day average of 0.21 and still historically low, suggesting options traders did not pivot to protection even after the print.
The Street remains cautiously positioned. Analyst data from mid-July shows a consensus mean target of $24.14, implying roughly 11% upside from current levels — a gap that has widened as the stock has drifted lower. The most recent moves on record (March, UBS to $24 neutral; Wells Fargo to $23 equal-weight; Goldman Sachs to $23 neutral in February) all kept neutral-to-cautious ratings even as they lifted targets. Morgan Stanley maintained underweight throughout. The pattern is consistent: Street targets have been moving up steadily for 18 months, yet no major house has upgraded to buy. The EV/EBITDA multiple has eased about 1.4% over the past month to roughly 10.4x, and the forward earnings yield implied by the factor scores (EPS 12-month forward year-on-year increase in the 99th percentile) suggests the growth angle is real — but the value score rank of 35 reflects the market's skepticism that the current price adequately discounts it.
Among midstream peers, the sector broadly softened this week. WMB fell 4.4% on the week and TRGP dropped 6.6%, making AM's 3.4% decline look relatively contained. EPD and HESM were the notable exceptions, each closing modestly positive on the week. The sector-wide weakness suggests the AM move is partly macro rather than company-specific — though AM's underperformance versus KMI (down 2.4%) is worth noting given their high correlation.
The next question is whether the Q2 numbers revealed anything that changes the insider-selling narrative — whether the cluster of March and May sales reflected routine compensation-driven trimming or something more fundamental about management's view of near-term throughput and distribution coverage. The short interest one-day spike that coincided with the print is worth tracking over the next few sessions: if it reverses quickly, it was a hedge unwound; if it holds or builds, it suggests the earnings response left bears with more conviction than before.
See the live data behind this article on ORTEX.
Open AM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
